How common is Dupuytren Disease?
How common is Dupuytren disease? The short answer is this: much more common than you might think. Scroll to the bottom to get the summary numbers. For the long answer, keep reading. The details depend on where you get your data. One set of data comes from a large web-based survey (DiBenedetti 2010). One conclusion […]
Read more ›
Dupuytren Disease Awareness Day!
On: Mar 20, 2017
By: Charles Eaton
Dupuytren Awareness Dupuytren disease research has a big problem: lack of awareness. Most people have never heard the word “Dupuytren”, much less “Dupuytren Disease”. The name “Dupuytren” is hard to pronounce and even harder to spell. Many other medical conditions have had this problem. Most have still not made it out into public. It takes work, […]
Read more ›
Dupuytren Foundation 2016 Mid-Year Report
On: Aug 30, 2016
By: Charles Eaton
Dupuytren Foundation 2016 Mid-Year Report 2016 has already exceeded expectations for the Dupuytren Foundation. Here are some of the highlights. Progress on International Dupuytren Data Bank Research The International Dupuytren Data Bank (IDDB) launched in November 2015. The goal of the IDDB is a cure for Dupuytren disease. This research has been made possible through your support. Project […]
Read more ›
Media coverage of Dupuytren Disease
On: Apr 18, 2016
By: Charles Eaton
There’s a been recent storm of Dupuytren related media coverage: A television news story interviewing Dupuytren Foundation executive director Dr. Charles Eaton and Dupuytren Foundation board member Tom Knapp: http://www.wpbf.com/news/whats-brewing-with-stephanie-berzinski-dupuytren-disease/39025076 Google books chose the chapter on Dupuytren disease authored by Dr. Charles Eaton to be the online example for the latest edition of the classic […]
Read more ›
First Dupuytren Nodule
On: Feb 2, 2016
By: Charles Eaton
My first Dupuytren palm nodule. What will to happen to me? Most Dupuytren disease starts as a nodule. Some nodules go away without any treatment. Some nodules develop minor cords and then seem to stop. Some nodules are the first sign of severe Dupuytren disease. Which is it going to be? Without a biomarker, we can […]
Read more ›
GivingTuesday Deal for the Dupuytren Foundation
On: Dec 1, 2015
By: Charles Eaton
It has been a great year – thanks to you! We’ve launched the International Dupuytren Data Bank (IDDB) – research for a cure, to be the largest Dupuytren study in history. Now that the IDDB is underway, your support is more important than ever. Please consider increasing your year-end gift to the Dupuytren Foundation this year […]
Read more ›
The Knowledge Gap
On: Jul 29, 2015
By: Charles Eaton
Dupuytren disease has fallen through a gap in a system which ordinarily leads to better and better disease treatment. One side of the gap is that at its core, Dupuytren disease is a medical disorder, from some subtle biologic imbalance. The other side is that although Dupuytren disease does many things, Dupuytren hand deformity has […]
Read more ›
2015 International Symposium on Dupuytren Disease
On: Jul 1, 2015
By: Charles Eaton
In: #Dupuytren,
Dupuytren contracture,
Dupuytren Foundation,
Dupuytren research,
Dupuytren Society,
Dupuytren Symposium,
Dupuytren's,
Dupuytren's Contracture,
Dupuytren's Diathesis,
Dupuytren's Disease,
Dupuytren's Symposium,
Fasciectomy,
Fasciotomy,
Genetics,
myofibroblast,
Needle Aponeurotomy,
Peyronie's,
Radiotherapy,
Recurrence,
Xiaflex
The May 2015 International Dupuytren Symposium in Groningen, The Netherlands was very productive. A textbook based on the proceedings is in the works. Video presentations are rolling out on http://Dupuytren.tv
Read more ›